113 related articles for article (PubMed ID: 38253940)
1. Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
Aksoy YA; Xu B; Viswanathan K; Ahadi MS; Al Ghuzlan A; Alzumaili B; Bani MA; Barletta JA; Chau N; Chou A; Clarkson A; Clifton-Bligh RJ; De Leo A; Dogan S; Ganly I; Ghossein R; Gild ML; Glover AR; Hadoux J; Lamartina L; Lubin DJ; Magliocca K; Najdawi F; Nigam A; Papachristos A; Repaci A; Robinson BG; Sheen A; Shi Q; Sidhu SB; Sioson L; Solaroli E; Sywak MS; Tallini G; Tsang V; Turchini J; Untch BR; Gill AJ; Fuchs TL
Histopathology; 2024 May; 84(6):947-959. PubMed ID: 38253940
[TBL] [Abstract][Full Text] [Related]
2. Construction and Validation of a Nomogram Based on the Log Odds of Positive Lymph Nodes to Predict the Prognosis of Medullary Thyroid Carcinoma After Surgery.
Tang J; Jiang S; Gao L; Xi X; Zhao R; Lai X; Zhang B; Jiang Y
Ann Surg Oncol; 2021 Aug; 28(8):4360-4370. PubMed ID: 33469797
[TBL] [Abstract][Full Text] [Related]
3. Independent Validation of the International Grading System for Medullary Thyroid Carcinoma: A Single Institution Experience.
Lubin DJ; Behrman DB; Goyal S; Magliocca K; Shi Q; Chen AY; Viswanathan K
Mod Pathol; 2023 Sep; 36(9):100235. PubMed ID: 37270155
[TBL] [Abstract][Full Text] [Related]
4. A novel prognostic nomogram for predicting survival in diffuse pleural mesothelioma.
Aksoy Y; Chou A; Mahjoub M; Sheen A; Sioson L; Ahadi MS; Gill AJ; Fuchs TL
Pathology; 2023 Jun; 55(4):449-455. PubMed ID: 36842876
[TBL] [Abstract][Full Text] [Related]
5. Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study.
Jiao Z; Wu T; Jiang M; Jiang S; Jiang K; Peng J; Luo G; Yu Y; Chen W; Yang A
Front Endocrinol (Lausanne); 2022; 13():1094242. PubMed ID: 36589824
[TBL] [Abstract][Full Text] [Related]
6. The Prediction of Metastases of Lateral Cervical Lymph Node in Medullary Thyroid Carcinoma.
Zhou TH; Zhao LQ; Zhang Y; Wu F; Lu KN; Mao LL; Jiang KC; Luo DC
Front Endocrinol (Lausanne); 2021; 12():741289. PubMed ID: 34867784
[TBL] [Abstract][Full Text] [Related]
7. The Establishment and Verification of a Nomogram Model for Predicting the Overall Survival of Medullary Thyroid Carcinoma: An Analysis Based on the SEER Database.
Wang W; Wang X; Che G; Qiao J; Chen Z; Liu J
Curr Oncol; 2023 Dec; 31(1):84-96. PubMed ID: 38248091
[TBL] [Abstract][Full Text] [Related]
8. External Validation of Three Available Grading Systems for Medullary Thyroid Carcinoma in a Single Institution Cohort.
Vissio E; Maletta F; Fissore J; Osella Abate S; Retta F; Brizzi MP; Piovesan A; Rossetto Giaccherino R; Volante M; Papotti M
Endocr Pathol; 2022 Sep; 33(3):359-370. PubMed ID: 35583706
[TBL] [Abstract][Full Text] [Related]
9. Predicting survival in colorectal carcinoma after curative resection: a new prognostic nomogram.
Mahjoub M; Sioson L; Sheen A; Ahadi M; Chou A; Gill AJ; Fuchs TL
Pathology; 2022 Feb; 54(1):79-86. PubMed ID: 34303553
[TBL] [Abstract][Full Text] [Related]
10. Establishment and validation of a nomogram model for predicting distant metastasis in medullary thyroid carcinoma: An analysis of the SEER database based on the AJCC 8th TNM staging system.
Chen Z; Mao Y; You T; Chen G
Front Endocrinol (Lausanne); 2023; 14():1119656. PubMed ID: 36875492
[TBL] [Abstract][Full Text] [Related]
11. Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: A cytologic-histologic correlation.
Viswanathan K; Behrman DB; Lubin DJ
Cancer Cytopathol; 2024 Apr; 132(4):224-232. PubMed ID: 38062948
[TBL] [Abstract][Full Text] [Related]
12. The novel prognostic nomograms for predicting cancer-specific survival and overall survival in mixed medullary and follicular cell carcinoma: A SEER-based study.
Li Y; Guo T; Gao X; Liu J
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16337-16354. PubMed ID: 37704803
[TBL] [Abstract][Full Text] [Related]
13. Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.
Ho AS; Wang L; Palmer FL; Yu C; Toset A; Patel S; Kattan MW; Tuttle RM; Ganly I
Ann Surg Oncol; 2015 Aug; 22(8):2700-6. PubMed ID: 25366585
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Nomogram for Predicting Survival in Patients with Thyroid Cancer.
Wen Q; Yu Y; Yang J; Wang X; Wen J; Wen Y; Wang Y; Lyu J
Med Sci Monit; 2019 Jul; 25():5561-5571. PubMed ID: 31350384
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram model for cancer-specific survival of patients with poorly differentiated thyroid carcinoma: A SEER database analysis.
Jin S; Liu H; Yang J; Zhou J; Peng D; Liu X; Zhang H; Zeng Z; Ye YN
Front Endocrinol (Lausanne); 2022; 13():882279. PubMed ID: 36176465
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
[TBL] [Abstract][Full Text] [Related]
17. Grading of Medullary Thyroid Carcinoma: an Interobserver Reproducibility Study.
Williams JF; Zhao M; Najdawi F; Ahmadi S; Hornick JL; Wong KS; Barletta JA
Endocr Pathol; 2022 Sep; 33(3):371-377. PubMed ID: 35553368
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study.
Wang J; Zhanghuang C; Jin L; Zhang Z; Tan X; Mi T; Liu J; Li M; Wu X; Tian X; He D
BMC Geriatr; 2022 Sep; 22(1):736. PubMed ID: 36076163
[TBL] [Abstract][Full Text] [Related]
20. Metastatic Risk Stratification of 2526 Medullary Thyroid Carcinoma Patients: A Study Based on Surveillance, Epidemiology, and End Results Database.
Le MK; Kawai M; Odate T; Vuong HG; Oishi N; Kondo T
Endocr Pathol; 2022 Sep; 33(3):348-358. PubMed ID: 35852678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
